Clinical Trial Update: Avoiding Neuromuscular Blockers to Reduce Complications [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating avoidance of neuromuscular blockers to reduce complications in respiratory failure/infection cases; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspiration Pneumonia
• Atelectasis
• Bronchospasm
• Pneumonitis
• Respiratory Failure
• Respiratory Infection

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Respiratory Failure, Respiratory Infection | Phase 4 | Status: TERMINATED